Brunei vs Sweden: The number of people with susceptibility test result for rifampicin
Brunei
162
in 2021
Sweden
173
in 2021
Brunei rank
99th
Sweden rank
97th
The number of people with susceptibility test result for rifampicin over time
- Brunei
- Sweden
How they compare
Sweden currently reports 173 against 162 in Brunei, a difference of 11.
That makes Sweden's figure about 1.1 times Brunei's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Sweden ahead.
Brunei ranks 99th and Sweden ranks 97th of 155 countries.
Across the 2 decades both report, Brunei averaged higher in 1 and Sweden in 1.
Head to head by decade
| Decade | Brunei | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 187 | 255 | 68 | Sweden |
| 2020s | 195.5 | 171 | 24.5 | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Brunei or Sweden?
- Sweden, at 173 against 162 in Brunei as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Brunei and Sweden?
- 11, with Sweden ahead.
- How many years of comparable data are there for Brunei and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Brunei and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Brunei ranks 99th and Sweden ranks 97th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.